Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics Inc. on the transaction. Denali Therapeutics (Nasdaq: DNLI) announced that it entered into a securities purchase agreement with...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Denali Therapeutics on the deal, while Davis Polk advised the representatives of the several underwriters. Denali Therapeutics, a biopharmaceutical company...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Blend on the deal while Goodwin Procter represented the underwriters. Blend Labs, Inc. announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal while Goodwin Procter LLP represented Marqeta, Inc. Marqeta announced the pricing of its initial public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised the underwriters on the deal. ThredUp Inc. (thredUP) announced the pricing of its initial public offering of 12,000,000 shares of...
You must be a Standard 1 Year member to access this content.
